As a result, we found that MEG3 presented similar expression levels in both contexts (p = 0.66), while ZEB1-AS1 showed a significantly higher expression in cancer samples (p = 3.983 × 10–09, Figure 5C). This evidence concerns the gene MEG3 and cancer.